Abstract
Piroxicam (PRM) and meloxicam (MEL) are two nonsteroidal anti-inflammatory drugs, belonging to the Biopharmaceutics Classification System Class II drugs. In this study, six novel pharmaceutical salts of PRM and MEL with three basic organic counterions, that is, 4-aminopyridine (4AP), 4-dimethylaminopyridine (4DMP), and piperazine (PPZ), were prepared by both slurrying and slow evaporation. These salts were characterized by single-crystal and powder X-ray diffraction, thermal analysis, and Fourier transform infrared spectroscopy. All six salts, especially MEL-4DMP and MEL-4AP, showed a significantly improved apparent solubility and dissolution rate in sodium phosphate solution compared with the pure APIs. Notably, PRM-4AP and PRM-4DMP salts exhibited enhanced fluorescence, and the PRM-PPZ salt showed weaker fluorescence compared with that of pure PRM due to different luminescence mechanisms.
| Original language | English |
|---|---|
| Pages (from-to) | 6504-6520 |
| Number of pages | 17 |
| Journal | Crystal Growth and Design |
| Volume | 22 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2 Nov 2022 |
Fingerprint
Dive into the research topics of 'Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions'. Together they form a unique fingerprint.Press/Media
-
New Findings from University College Cork Update Understanding of Piroxicam Therapy (Pharmaceutical Salts of Piroxicam and Meloxicam With Organic Counterions)
30/11/22
1 item of Media coverage
Press/Media
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver